Nasser Khan
Impact in
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 20
- Rheumatoid Arthritis Research and Therapies 19
- Urticaria and Related Conditions 1
- Genetics 2
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Aileen L. Pangan (3 shared papers)Heidi S. Camp (8 shared papers)Jeffrey Enejosa (3 shared papers)Gerd R Burmester (6 shared papers)Li Wang (2 shared papers)Ahmed A. Othman (2 shared papers)Steven Jungerwirth (2 shared papers)Yoshiya Tanaka (7 shared papers)
- Journals
- RMD Open (5 papers)Arthritis & Rheumatology (4 papers)Rheumatology and Therapy (4 papers)Annals of the Rheumatic Diseases (3 papers)Arthritis Care & Research (1 paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Nasser Khan
27 papers receiving 1.0k citations
Nasser Khan's Hit Papers
Peers
Comparison fields: 5 of 65
- Rheumatology 627
- Hematology 191
- Genetics 110
- Oncology 214
- Immunology 161
Countries citing papers authored by Nasser Khan
This map shows the geographic impact of Nasser Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasser Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasser Khan more than expected).
Fields of papers citing papers by Nasser Khan
This network shows the impact of papers produced by Nasser Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasser Khan. The network helps show where Nasser Khan may publish in the future.
Co-authors
The 25 scholars most cited alongside Nasser Khan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis Hit paper breakdown → | 2020 | 189 |
| 2 | Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme Hit paper breakdown → | 2020 | 184 |
| 3 | 2016 | 170 | |
| 4 | 2016 | 148 | |
| 5 | 2022 | 74 | |
| 6 | 2018 | 66 | |
| 7 | 2022 | 56 | |
| 8 | 2017 | 29 | |
| 9 | 2019 | 21 | |
| 10 | 2023 | 18 | |
| 11 | 2021 | 18 | |
| 12 | 2024 | 11 | |
| 13 | 2024 | 7 | |
| 14 | 2024 | 6 | |
| 15 | 2024 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2024 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2024 | 4 | |
| 20 | 2024 | 4 |
About Nasser Khan
Nasser Khan is a scholar working on Rheumatology, Genetics, Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Dermatology, having authored 27 papers that have together received 1.0k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (19 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cardiovascular Disease and Adiposity (2 papers), Cardiovascular Health and Disease Prevention (1 paper), Soil Carbon and Nitrogen Dynamics (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Urticaria and Related Conditions (1 paper) and Biosimilars and Bioanalytical Methods (1 paper). The work is most often cited by research in Rheumatology (627 citations), Hematology (191 citations), Genetics (110 citations), Oncology (214 citations) and Immunology (161 citations). Nasser Khan has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Aileen L. Pangan, Heidi S. Camp, Jeffrey Enejosa, Gerd R Burmester, Li Wang, Ahmed A. Othman, Steven Jungerwirth, Yoshiya Tanaka, Louis Bessette and Kevin Winthrop. Their work appears in journals such as RMD Open, Arthritis & Rheumatology, Rheumatology and Therapy, Annals of the Rheumatic Diseases and Arthritis Care & Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.